1. Home
  2. PDYN vs EDIT Comparison

PDYN vs EDIT Comparison

Compare PDYN & EDIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PDYN
  • EDIT
  • Stock Information
  • Founded
  • PDYN 1983
  • EDIT 2013
  • Country
  • PDYN United States
  • EDIT United States
  • Employees
  • PDYN N/A
  • EDIT N/A
  • Industry
  • PDYN Wholesale Distributors
  • EDIT Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • PDYN Industrials
  • EDIT Health Care
  • Exchange
  • PDYN Nasdaq
  • EDIT Nasdaq
  • Market Cap
  • PDYN 271.4M
  • EDIT 269.8M
  • IPO Year
  • PDYN N/A
  • EDIT 2016
  • Fundamental
  • Price
  • PDYN $9.90
  • EDIT $3.95
  • Analyst Decision
  • PDYN Hold
  • EDIT Buy
  • Analyst Count
  • PDYN 1
  • EDIT 11
  • Target Price
  • PDYN $8.00
  • EDIT $4.56
  • AVG Volume (30 Days)
  • PDYN 2.5M
  • EDIT 2.8M
  • Earning Date
  • PDYN 11-12-2025
  • EDIT 11-03-2025
  • Dividend Yield
  • PDYN N/A
  • EDIT N/A
  • EPS Growth
  • PDYN N/A
  • EDIT N/A
  • EPS
  • PDYN N/A
  • EDIT N/A
  • Revenue
  • PDYN $4,357,000.00
  • EDIT $38,901,000.00
  • Revenue This Year
  • PDYN N/A
  • EDIT N/A
  • Revenue Next Year
  • PDYN $97.52
  • EDIT N/A
  • P/E Ratio
  • PDYN N/A
  • EDIT N/A
  • Revenue Growth
  • PDYN N/A
  • EDIT N/A
  • 52 Week Low
  • PDYN $1.69
  • EDIT $0.91
  • 52 Week High
  • PDYN $14.95
  • EDIT $4.07
  • Technical
  • Relative Strength Index (RSI)
  • PDYN 68.16
  • EDIT 71.08
  • Support Level
  • PDYN $8.26
  • EDIT $3.01
  • Resistance Level
  • PDYN $9.25
  • EDIT $4.06
  • Average True Range (ATR)
  • PDYN 0.75
  • EDIT 0.30
  • MACD
  • PDYN 0.18
  • EDIT 0.08
  • Stochastic Oscillator
  • PDYN 83.39
  • EDIT 89.89

About PDYN Palladyne AI Corp.

Palladyne AI Corp is a software company focused on autonomy for robotic systems and solutions. Its artificial intelligence and machine learning software seeks to revolutionize the capabilities of robots, enabling them to observe, learn, reason, and act in structured and unstructured environments. AI and ML software platform of the company empowers robots to perceive variations or changes in the real-world environment, enabling them to autonomously maneuver and manipulate objects accurately in response. Palladyne AI software has wide application, including in industries such as automotive, aviation, construction, defense, general manufacturing, infrastructure inspection, logistics and warehousing.

About EDIT Editas Medicine Inc.

Editas Medicine Inc is a clinical-stage genome editing company dedicated to developing potentially transformative genomic medicines to treat a broad range of serious diseases. The company focuses on developing a proprietary genome editing platform based on clustered, regularly interspaced short palindromic repeats (CRISPR)/ CRISPR-associated protein 9 (Cas9 technology). It has developed CRISPR/Cas9 technology which uses a protein-RNA (ribonucleic acid) complex composed of the Cas9 enzyme bound to a guide RNA molecule designed to recognize a DNA (deoxyribonucleic acid) sequence that requires repair. The company is engaged in developing and commercializing genome editing technology.

Share on Social Networks: